See what ashwagandha is moving
Check cortisol, thyroid, liver, and testosterone markers before and after 8 weeks
- CLIA-certified labs
- HIPAA compliant
- Personalized health protocol
What is ashwagandha?
Ashwagandha is an evergreen shrub, Withania somnifera, whose root has been used in Ayurvedic medicine for centuries and is sold today as a dietary supplement marketed for stress, sleep, and anxiety. You will also see it labeled Indian ginseng or winter cherry. Marketers file it under "adaptogen," a category term for herbs claimed to help the body handle stress.
That category label carries no regulatory weight. Ashwagandha is sold as a supplement, not a medicine, so it never had to prove anything to reach a shelf. The human research is limited, with many trials small and using varied preparations. That is the honest starting point.
What are withanolides?
Withanolides are the naturally occurring steroidal lactones in ashwagandha that supplement labels standardize against. Withaferin A and withanolide A are the most-studied individual compounds, alongside alkaloids and sitoindosides.
Here is why that standardization number matters: the constituent profile differs by plant part and growing conditions. Two bottles labeled "ashwagandha" can contain very different amounts of the compounds trials actually tested.
What does ashwagandha do in the body?
The best-documented human effects of ashwagandha are reductions in perceived stress and in circulating cortisol, the body's main stress hormone.
How it gets there is less settled. In the laboratory, aqueous ashwagandha root extract directly activates ionotropic GABA-A channels and acts as a potent agonist at GABA-rho1 receptors, a signalling route consistent with calming and sleep effects. Curiously, withaferin A and withanolide A on their own did not activate either receptor. This is receptor-level evidence in a dish, not proof that the same thing happens in people.
Whatever the route, the biological activity is real enough to show up on a lab report. In adults with elevated TSH, 600 mg per day for 8 weeks significantly shifted TSH, T3, and T4. That is a measurable hormonal effect, not evidence of a therapeutic benefit.
What are the evidence-backed benefits of ashwagandha?
Pooled trial data most consistently support reductions in stress and anxiety. Everything else, sleep, physical performance, male hormones and fertility, blood sugar, and cognition, is a smaller and less certain signal.
The limitations apply to all of it, so they are worth stating once. Trials are mostly small and of short duration, several are industry-funded, and for the stress and anxiety outcomes the certainty of evidence was rated low with very high heterogeneity. Long-term safety is unknown.
Stress and cortisol
The strongest case for ashwagandha sits here. Across 9 randomized trials in 558 participants, ashwagandha significantly improved Perceived Stress Scale scores (MD −4.72) and lowered serum cortisol (MD −2.58) versus placebo.
The trial that supplies the dose most people are looking for enrolled 64 chronically stressed adults on 300 mg of a high-concentration full-spectrum root extract twice daily for 60 days. They ended with significantly lower stress-scale scores (P<0.0001) and serum cortisol (P=0.0006) than placebo, and mild adverse effects comparable to placebo.
Dose appears to matter. When 60 stressed adults took 125 mg, 300 mg, or placebo twice daily for 8 weeks, perceived stress fell at 250 mg per day and more strongly at 600 mg per day, with cortisol falling at both doses.
Sleep quality
Ashwagandha helps sleep, modestly, and mostly for people who are already sleeping badly. Across 5 randomized trials in 400 participants, ashwagandha extract produced a small but significant improvement in overall sleep (SMD −0.59), concentrated in adults with insomnia and at doses of at least 600 mg per day taken for at least 8 weeks.
The trial-level data show which parts of the night change. In 80 participants studied for 8 weeks, sleep onset latency and sleep efficiency improved most, followed by total sleep time and wake after sleep onset, with bigger gains in the insomnia group than in healthy sleepers. If you already sleep well, expect less.
Anxiety and mood
Pooling 12 randomized trials in 1,002 participants, ashwagandha reduced anxiety (SMD −1.55) and stress (SMD −1.75) versus placebo, with the largest stress benefit in the 300 to 600 mg per day range. Those are large effect sizes, which is exactly why they deserve scrutiny: heterogeneity across the trials very high (I² 83.1% for stress, 93.8% for anxiety) and certainty of evidence was low. The direction of the effect is clearer than its size, and none of this makes ashwagandha a therapy for an anxiety disorder.
Strength, endurance, and recovery
The performance data are more encouraging than most people expect. A Bayesian meta-analysis of 12 studies found ashwagandha outperformed placebo on strength, power, cardiorespiratory fitness, and fatigue-recovery outcomes in healthy men and women, with the authors calling for more trials in trained athletes.
Two numbers carry the section. Pooled across 4 studies in 142 participants, VO2max rose by about 3.00 mL/kg/min. And in 57 untrained young men taking 300 mg root extract twice daily alongside 8 weeks of resistance training, bench-press one-rep max gains were roughly 46.0 kg versus 26.4 kg on placebo, though training novices improve fast on almost any program, so those gains do not transfer cleanly to trained lifters.
Testosterone and male fertility
Ashwagandha has moved male hormone levels in small trials, but the hormone changes have not reliably translated into how men feel. In 57 overweight men aged 40 to 70 taking a standardized extract delivering 21 mg of withanolide glycosides daily for 8 weeks, salivary testosterone rose 14.7% and DHEA-S 18% more than placebo, yet there were no significant between-group differences in fatigue, vigor, or sexual well-being.
The fertility evidence is thinner still. In a pilot study of 46 men with low sperm counts, 675 mg per day of full-spectrum root extract in three divided doses for 90 days raised sperm count by 167%, semen volume by 53%, and motility by 57% within the supplemented group. That was a small pilot in men with an existing sperm-count problem, not evidence of a fertility benefit in healthy men.
Blood sugar, inflammation, and memory
The metabolic story is mostly animal and cell data wearing a clinical costume. A systematic review that included only 5 clinical studies alongside 13 pre-clinical and 6 in-vitro studies reported improvements in blood glucose, HbA1c, insulin, lipid, and oxidative-stress markers, while the authors concluded the clinical data are not robust enough to support ashwagandha in diabetes management.
Cognition has a similar ceiling. A systematic review found only 5 eligible clinical studies in a heterogeneous population, most showing better cognitive task performance, executive function, attention, and reaction time, with the authors calling the evidence early. The concrete trial: 50 adults taking 300 mg root extract twice daily for 8 weeks improved on immediate and general memory subtests plus executive function and attention. Those participants had mild cognitive impairment, not healthy baseline memory.
How much ashwagandha should you take, and when?
Most trials use 300 to 600 mg per day of root extract standardized to about 5% withanolides, taken for at least 8 weeks before judging any effect. A joint WFSBP and CANMAT taskforce provisionally recommends 300 to 600 mg per day of that standardization for generalized anxiety.
| Goal | Studied daily dose | Timing | Minimum duration | |---|---|---|---| | Stress and cortisol | 300 mg twice daily | Morning and evening | 60 days | | Sleep | At least 600 mg | Timing not tested | 8 weeks | | Strength and recovery | 300 mg twice daily | With training days | 8 weeks | | Memory | 300 mg twice daily | Morning and evening | 8 weeks | | Male fertility | 675 mg total | Three divided doses | 90 days |
Timing follows the goal rather than a rule. Sleep benefits concentrated at 600 mg per day or more for 8 weeks or longer rather than at any particular time of day, while stress dosing is typically split between morning and evening. Splitting the daily total is simply what the trials did.
A sensible starting sequence looks like the one used in the controlled safety research, which tested labs at baseline and again at week 8:
- Confirm no contraindication applies to you.
- Check baseline labs.
- Begin at the low end of the studied range.
- Hold that dose for 8 weeks.
- Reassess symptoms and repeat the same labs.
Which ashwagandha form matches the trial evidence?
Ashwagandha products differ in which plant part they use and how much withanolide content they guarantee, and those differences are why an unstandardized root powder cannot be assumed to behave like the extracts used in trials, given how much the constituent profile shifts with plant part and growing conditions.
| Product type | Plant part | Withanolide standardization | Trial evidence it maps to | |---|---|---|---| | Standardized root extract | Root | About 5% withanolides | The 300 to 600 mg daily dosing | | Withanolide-glycoside extract | Root | 21 mg glycosides daily | Male hormone crossover trial | | Full-spectrum root extract | Root | High-concentration, full spectrum | Stress and fertility trials | | Unstandardized root powder | Root | None guaranteed | No trial dosing to match |
Read the label for two things: the withanolide percentage or milligram content, and the plant part. Because trials used different extraction and standardization processes, it is difficult to identify a specific extract or recommended amount that applies across products.
How long does ashwagandha take to work?
Give it 8 weeks. The pooled sleep trials ran 6 to 12 weeks, with benefits more prominent at 8 weeks or longer, so anything shorter is a coin flip rather than a fair test.
Symptom scales and cortisol shifted over these same 8 to 12 week windows in the pooled data, with benefits clustering in studies lasting at least 8 weeks. A fair trial period means holding the studied dose and reassessing at the end, not judging week to week.
Who should not take ashwagandha?
Several groups are advised to avoid ashwagandha entirely, and the caution is strongest in pregnancy, before surgery, and in hormone-sensitive prostate cancer, and in cirrhosis or advanced chronic liver disease.
The groups told to steer clear or talk to a clinician first:
- Pregnancy and breastfeeding
- Existing liver disease or cirrhosis
- Thyroid disorders or levothyroxine use
- Autoimmune conditions
- Hormone-sensitive prostate cancer
- Anyone with surgery scheduled
- Anyone taking sedatives or immunosuppressants
Two of those carry the highest stakes. Ashwagandha may raise testosterone, which is the reason it is avoided in hormone-sensitive prostate cancer. And in a case series of 8 single-ingredient herb-induced liver injury cases, the three patients who presented with acute-on-chronic liver failure all had underlying chronic liver disease and all died on follow-up. If you are in any of these groups, this is a conversation with a clinician rather than a dose to figure out alone.
What are the side effects and drug interactions?
Most reported side effects of ashwagandha are mild and transient, though rare cases of clinically apparent liver injury are documented.
Somnolence, epigastric discomfort, and loose stools were the only ones reported in more than 5% of participants across 30 human trials; stomach upset, diarrhea, and vomiting and nausea round out the common mild effects:
- Drowsiness or somnolence
- Epigastric pain or stomach discomfort
- Loose stools or diarrhea
- Nausea or vomiting
Controlled data are reassuring at typical doses and durations. In 80 healthy adults given 300 mg root extract twice daily for 8 weeks with hematology, liver-function, and thyroid panels at baseline and week 8, no significant changes or abnormalities were seen and no adverse events were reported.
The hepatotoxicity signal deserves specifics rather than a vague warning. Liver injury typically appears 2 to 12 weeks after starting ashwagandha, with a cholestatic or mixed pattern, jaundice, and itching. Across a 5-patient case series, all developed jaundice with nausea, lethargy, pruritus, and abdominal discomfort, none developed hepatic failure, and liver tests normalized within 1 to 5 months in those followed up.
Signs that warrant stopping and calling a clinician about your liver:
- Yellowing of the skin or eyes
- Dark urine
- Itching
- Pain under the right ribs
- Unusual fatigue or loss of appetite
Interactions and thyroid effects belong in the same breath, because both involve something you may already be taking. Ashwagandha may interact with sedatives, immunosuppressants, and thyroid hormone medications and warrants caution before surgery. And a 73-year-old woman who self-managed hypothyroidism with ashwagandha root extract for two years developed thyrotoxicosis with supraventricular tachycardia and markedly suppressed TSH that resolved after stopping.
Which biomarkers to check before and during ashwagandha use
Ashwagandha measurably moves cortisol, thyroid hormones, and testosterone, and it is a documented cause of liver injury, so the informative approach is a baseline panel before starting and a repeat after about 8 weeks, which is exactly the testing schedule the controlled safety research used.
| Marker | Why it is relevant | When to check | |---|---|---| | Cortisol | The outcome pooled trials most consistently moved | Baseline and week 8 | | TSH and free T4 | Ashwagandha shifts thyroid hormones | Baseline and week 8 | | ALT and AST | Liver injury reported 2 to 12 weeks in | Baseline and week 8 | | Testosterone and DHEA-S | Both rose in older overweight men | Baseline and week 8 | | Fasting glucose and HbA1c | Markers moved in a small evidence base | Baseline and week 8 |
Each row rests on a measured change: the pooled cortisol estimate, the TSH, T3, and T4 shifts plus a documented thyrotoxicosis case, the 2 to 12 week liver injury window, the testosterone and DHEA-S increases, and metabolic marker changes in a thin evidence base.
A baseline result is what makes an 8-week recheck mean anything, because without it a number is just a number. Any marker that moves is a conversation for a clinician who knows your full medication list.
Track what ashwagandha moves with a Superpower blood panel
The honest way to know whether ashwagandha is helping, or quietly moving something it should not, is to measure before and after rather than guess from how you feel. The Superpower Blood Panel covers cortisol, TSH, ALT and AST, and total and free testosterone from a single draw, which gives you the baseline an 8-week recheck needs, and Superpower reads the results back to you in plain language.
Frequently Asked Questions
References
- Mikulska P, Malinowska M, Ignacyk M, et al. (2023). Ashwagandha (Withania somnifera)—current research on the health-promoting activities: a narrative review. *Pharmaceutics*, *15*(4), 1057. https://doi.org/10.3390/pharmaceutics15041057
- National Center for Complementary and Integrative Health. (2023). *Ashwagandha* [Herbs at a glance]. National Institutes of Health. https://www.nccih.nih.gov/health/ashwagandha
- Arumugam V, Vijayakumar V, Balakrishnan A, et al. (2024). Effects of ashwagandha (Withania somnifera) on stress and anxiety: a systematic review and meta-analysis. *Explore*, *20*(6), 103062. https://doi.org/10.1016/j.explore.2024.103062
- Candelario M, Cuellar E, Reyes-Ruiz JM, et al. (2015). Direct evidence for GABAergic activity of Withania somnifera on mammalian ionotropic GABAA and GABAρ receptors. *Journal of Ethnopharmacology*, *171*, 264–272. https://doi.org/10.1016/j.jep.2015.05.058
- Sharma AK, Basu I, Singh S (2018). Efficacy and safety of ashwagandha root extract in subclinical hypothyroid patients: a double-blind, randomized placebo-controlled trial. *Journal of Alternative and Complementary Medicine*, *24*(3), 243–248. https://doi.org/10.1089/acm.2017.0183
- Akhgarjand C, Asoudeh F, Bagheri A, et al. (2022). Does ashwagandha supplementation have a beneficial effect on the management of anxiety and stress? A systematic review and meta-analysis of randomized controlled trials. *Phytotherapy Research*, *36*(11), 4115–4124. https://doi.org/10.1002/ptr.7598
- National Institutes of Health, Office of Dietary Supplements. (2025). *Ashwagandha: is it helpful for stress, anxiety, or sleep? Health professional fact sheet*. https://ods.od.nih.gov/factsheets/Ashwagandha-HealthProfessional/
- Chandrasekhar K, Kapoor J, Anishetty S (2012). A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults. *Indian Journal of Psychological Medicine*, *34*(3), 255–262. https://doi.org/10.4103/0253-7176.106022
- Salve J, Pate S, Debnath K, Langade D (2019). Adaptogenic and anxiolytic effects of ashwagandha root extract in healthy adults: a double-blind, randomized, placebo-controlled clinical study. *Cureus*, *11*(12), e6466. https://doi.org/10.7759/cureus.6466
- Cheah KL, Norhayati MN, Husniati Yaacob L, Abdul Rahman R (2021). Effect of ashwagandha (Withania somnifera) extract on sleep: a systematic review and meta-analysis. *PLoS ONE*, *16*(9), e0257843. https://doi.org/10.1371/journal.pone.0257843
- Langade D, Thakare V, Kanchi S, Kelgane S (2021). Clinical evaluation of the pharmacological impact of ashwagandha root extract on sleep in healthy volunteers and insomnia patients: a double-blind, randomized, parallel-group, placebo-controlled study. *Journal of Ethnopharmacology*, *264*, 113276. https://doi.org/10.1016/j.jep.2020.113276
- Bonilla DA, Moreno Y, Gho C, et al. (2021). Effects of ashwagandha (Withania somnifera) on physical performance: systematic review and Bayesian meta-analysis. *Journal of Functional Morphology and Kinesiology*, *6*(1), 20. https://doi.org/10.3390/jfmk6010020
- Pérez-Gómez J, Villafaina S, Adsuar JC, Merellano-Navarro E, Collado-Mateo D (2020). Effects of ashwagandha (Withania somnifera) on VO2max: a systematic review and meta-analysis. *Nutrients*, *12*(4), 1119. https://doi.org/10.3390/nu12041119
- Wankhede S, Langade D, Joshi K, Sinha SR, Bhattacharyya S (2015). Examining the effect of Withania somnifera supplementation on muscle strength and recovery: a randomized controlled trial. *Journal of the International Society of Sports Nutrition*, *12*, 43. https://doi.org/10.1186/s12970-015-0104-9
- Lopresti AL, Drummond PD, Smith SJ (2019). A randomized, double-blind, placebo-controlled, crossover study examining the hormonal and vitality effects of ashwagandha (Withania somnifera) in aging, overweight males. *American Journal of Men's Health*, *13*(2), 1557988319835985. https://doi.org/10.1177/1557988319835985
- Ambiye VR, Langade D, Dongre S, Aptikar P, Kulkarni M, Dongre A (2013). Clinical evaluation of the spermatogenic activity of the root extract of ashwagandha (Withania somnifera) in oligospermic males: a pilot study. *Evidence-Based Complementary and Alternative Medicine*, *2013*, 571420. https://doi.org/10.1155/2013/571420
- Durg S, Bavage S, Shivaram SB (2020). Withania somnifera (Indian ginseng) in diabetes mellitus: a systematic review and meta-analysis of scientific evidence from experimental research to clinical application. *Phytotherapy Research*, *34*(5), 1041–1059. https://doi.org/10.1002/ptr.6589
- Ng QX, Loke W, Foo NX, et al. (2020). A systematic review of the clinical use of Withania somnifera (ashwagandha) to ameliorate cognitive dysfunction. *Phytotherapy Research*, *34*(3), 583–590. https://doi.org/10.1002/ptr.6552
- Choudhary D, Bhattacharyya S, Bose S (2017). Efficacy and safety of ashwagandha (Withania somnifera (L.) Dunal) root extract in improving memory and cognitive functions. *Journal of Dietary Supplements*, *14*(6), 599–612. https://doi.org/10.1080/19390211.2017.1284970
- Verma N, Gupta SK, Tiwari S, Mishra AK (2021). Safety of ashwagandha root extract: a randomized, placebo-controlled study in healthy volunteers. *Complementary Therapies in Medicine*, *57*, 102642. https://doi.org/10.1016/j.ctim.2020.102642
- National Institute of Diabetes and Digestive and Kidney Diseases (2024). *Ashwagandha*. In LiverTox: clinical and research information on drug-induced liver injury. National Institute of Diabetes and Digestive and Kidney Diseases. https://www.ncbi.nlm.nih.gov/books/NBK548536/
- Philips CA, Valsan A, Theruvath AH, et al. (2023). Ashwagandha-induced liver injury—a case series from India and literature review. *Hepatology Communications*, *7*(10), e0270. https://doi.org/10.1097/HC9.0000000000000270
- Tandon N, Yadav SS (2020). Safety and clinical effectiveness of Withania somnifera (Linn.) Dunal root in human ailments. *Journal of Ethnopharmacology*, *255*, 112768. https://doi.org/10.1016/j.jep.2020.112768
- Björnsson HK, Björnsson ES, Avula B, et al. (2020). Ashwagandha-induced liver injury: a case series from Iceland and the US Drug-Induced Liver Injury Network. *Liver International*, *40*(4), 825–829. https://doi.org/10.1111/liv.14393
- Kamal HI, Patel K, Brdak A, Heffernan J, Ahmad N (2022). Ashwagandha as a unique cause of thyrotoxicosis presenting with supraventricular tachycardia. *Cureus*, *14*(3), e23494. https://doi.org/10.7759/cureus.23494















